OTCMKTS:AOLS

Aeolus Pharmaceuticals Stock Insider Trading

> Drug Manufacturers - Specialty & Generic

Buy AOLS

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Aeolus Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 8.68M and sold 0 AOLS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	8.68M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 28, 2016 Buy	Common Stock A-Award	Mcmanus John L President And CEO	CEO / President	25 000 Value: $4K
Dec 28, 2016 Buy	Common Stock A-Award	Mcmanus John L President And CEO	CEO / President	25 000 Value: $4K
Mar 04, 2016 Buy	Incentive Stock Option (right to buy) A-Award	Mcmanus John L President And CEO	CEO / President	250 000 Value: $46.4K
Mar 04, 2016 Buy	Incentive Stock Option (right to buy) A-Award	Mcmanus John L President And CEO	CEO / President	250 000 Value: $46.4K
Oct 01, 2015 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $25.0K
Oct 01, 2015 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $25.0K
Mar 04, 2015 Buy	Incentive Stock Option (right to buy) A-Award	Mcmanus John L President And CEO	CEO / President	250 000 Value: $67.1K
Mar 04, 2015 Buy	Incentive Stock Option (right to buy) A-Award	Mcmanus John L President And CEO	CEO / President	250 000 Value: $67.1K
Oct 01, 2014 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $24.0K
Oct 01, 2014 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $24.0K
Mar 04, 2014 Buy	Incentive Stock Option (right to buy) A-Award	Mcmanus John L President And CEO	CEO / President	250 000 Value: $66.3K
Mar 04, 2014 Buy	Incentive Stock Option (right to buy) A-Award	Mcmanus John L President And CEO	CEO / President	250 000 Value: $66.3K
Oct 01, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $26.1K
Oct 01, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $26.1K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Cavalier David Director	Director	75 000 Value: $33.0K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Suzdak Peter David Director	Director	75 000 Value: $33.0K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Lewis Michael E Director	Director	75 000 Value: $33.0K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $44.0K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Kumar Amit Director	Director	100 000 Value: $44.0K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Lewis Michael E Director	Director	75 000 Value: $33.0K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Suzdak Peter David Director	Director	75 000 Value: $33.0K
May 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Cavalier David Director	Director	75 000 Value: $33.0K
Mar 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Skibsted Russell Chief Financial Officer	C-Suite Officer	150 000 Value: $57.0K
Mar 08, 2013 Buy	Non-qualified Stock Option (right to buy) A-Award	Skibsted Russell Chief Financial Officer	C-Suite Officer	150 000 Value: $57.0K
Mar 06, 2013 Buy	Common Stock P-Purchase	Mcmanus John L President And CEO	CEO / President	10 000 Value: $4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AEOLUS PHARMACEUTICALS, INC.

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and on...

Read Full Profile Here